MedPage Today on MSN
GLP-1 Drugs Show Benefits in Lupus Patients With Diabetes
Patients with systemic lupus erythematosus (SLE) and type 2 diabetes, with and without lupus nephritis (LN), had a lower risk ...
In the Jewish tradition, Yom Kippur—the holiest day of the year—is a 25-hour Day of Atonement devoted to self-reflection, repentance (teshuvah), and prayer. For those managing a chronic illness like ...
Without naming Aurinia Pharmaceuticals, the CDER director in a now-deleted LinkedIn post claimed that for lupus nephritis, ...
Objective Pregnant patients with systemic lupus erythematosus (SLE) have 2-3 times higher risk of preterm delivery (PTD).
Halsey gives fans an update about her tour and health. The post Halsey Shares Health Update After Doing ‘Another Few Sessions ...
Breakthrough T1D (formerly JDRF), the Lupus Research Alliance, and the National Multiple Sclerosis Society today announce the ...
MedPage Today on MSN
Ulcerative Colitis: Next Target for CAR T-Cell Therapy?
The range of autoimmune diseases treatable with chimeric antigen receptor (CAR) T-cell therapy could be much broader than ...
Anifrolumab, a type I interferon receptor antagonist, is currently approved under the brand name Saphnelo for IV administration in the treatment of moderate to severe SLE.
The Lupus Foundation of America Engages the Food and Drug Administration on Inclusion of Pregnant and Breastfeeding Women in Clinical Trials.
Halsey shared a rare update on her life, including going undergoing chemotherapy for treating her lupus and T-cell ...
Aurinia Pharmaceuticals (AUPH) stock gains as the company defends its lead drug Lupkynis after a top FDA regulator linked it ...
Explore practical implications of new research in nephrotic syndrome, from renal biopsy and genetic testing to managing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results